Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Low-Dose Antiangiogenic Chemotherapy in Combination With Standard Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma Family of Tumors

NCT00061893 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00061893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00061893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Low-Dose Antiangiogenic Chemotherapy in Combination With Standard Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma Family of Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2013
Enrollment
38 (actual)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma